Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Heterotopic production of ceruloplasmin by lung adenocarcinoma is significantly correlated with prognosis.

Matsuoka R, Shiba-Ishii A, Nakano N, Togayachi A, Sakashita S, Sato Y, Minami Y, Noguchi M.

Lung Cancer. 2018 Apr;118:97-104. doi: 10.1016/j.lungcan.2018.01.012. Epub 2018 Feb 3.

PMID:
29572010
2.

Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.

Guo T, Zhao S, Li Z, Li F, Li J, Gu C.

Cancer Biomark. 2018;22(2):301-310. doi: 10.3233/CBM-171017.

PMID:
29630522
3.

Prognostic value of decreased GRK6 expression in lung adenocarcinoma.

Yao S, Zhong L, Liu J, Feng J, Bian T, Zhang Q, Chen J, Lv X, Chen J, Liu Y.

J Cancer Res Clin Oncol. 2016 Dec;142(12):2541-2549. Epub 2016 Sep 6.

PMID:
27601164
4.

Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.

Kim Y, Shiba-Ishii A, Nakagawa T, Husni RE, Sakashita S, Takeuchi T, Noguchi M.

Pathol Int. 2017 Jun;67(6):292-301. doi: 10.1111/pin.12546. Epub 2017 May 19.

PMID:
28544031
5.

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.

Zhang Z, Wang A, Sun B, Zhan Z, Chen K, Wang C.

J Cardiothorac Surg. 2013 Apr 16;8:95. doi: 10.1186/1749-8090-8-95.

6.

High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma.

Zhang J, Ni SS, Zhao WL, Dong XC, Wang JL.

Tumour Biol. 2013 Aug;34(4):2397-401. doi: 10.1007/s13277-013-0789-9. Epub 2013 Apr 18.

PMID:
23595221
7.
8.

Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).

Shimoji M, Shimizu S, Sato K, Suda K, Kobayashi Y, Tomizawa K, Takemoto T, Mitsudomi T.

Lung Cancer. 2016 Aug;98:69-75. doi: 10.1016/j.lungcan.2016.04.021. Epub 2016 May 25.

PMID:
27393509
9.

Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.

Luo HT, Liang CX, Luo RC, Gu WG.

Biosci Rep. 2017 Nov 6;37(6). pii: BSR20171086. doi: 10.1042/BSR20171086. Print 2017 Dec 22.

10.

Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.

Cui Y, Liu J, Yin HB, Liu YF, Liu JH.

Jpn J Clin Oncol. 2015 Sep;45(9):854-9. doi: 10.1093/jjco/hyv094. Epub 2015 Jul 16.

PMID:
26185140
11.

The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.

Oktay E, Oflazoglu U, Varol Y, Tanriverdi O, Mermur N, Arda HU, Demir L, Keskin O, Ahmadli T, Somali I, Oztop I, Meydan N.

J Cancer Res Ther. 2018 Dec;14(Supplement):S1201-S1208. doi: 10.4103/jcrt.JCRT_1404_16.

12.

Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.

Mo ML, Okamoto J, Chen Z, Hirata T, Mikami I, Bosco-Clément G, Li H, Zhou HM, Jablons DM, He B.

PLoS One. 2013 Aug 16;8(8):e71816. doi: 10.1371/journal.pone.0071816. eCollection 2013.

13.

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.

Okabe N, Ezaki J, Yamaura T, Muto S, Osugi J, Tamura H, Imai J, Ito E, Yanagisawa Y, Honma R, Gotoh M, Watanabe S, Waguri S, Suzuki H.

Int J Oncol. 2015 Mar;46(3):999-1006. doi: 10.3892/ijo.2015.2817. Epub 2015 Jan 7.

14.

DNMT3a expression pattern and its prognostic value in lung adenocarcinoma.

Husni RE, Shiba-Ishii A, Iiyama S, Shiozawa T, Kim Y, Nakagawa T, Sato T, Kano J, Minami Y, Noguchi M.

Lung Cancer. 2016 Jul;97:59-65. doi: 10.1016/j.lungcan.2016.04.018. Epub 2016 Apr 27.

PMID:
27237029
15.

Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.

Chao YC, Pan SH, Yang SC, Yu SL, Che TF, Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, Lee YC, Hong TM, Yang PC.

Am J Respir Crit Care Med. 2009 Jan 15;179(2):123-33. doi: 10.1164/rccm.200803-456OC. Epub 2008 Sep 11.

PMID:
18787218
16.

Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma.

Yu J, Wang L, Zhang T, Shen H, Dong W, Ni Y, Du J.

Tumour Biol. 2015 Aug;36(8):6551-8. doi: 10.1007/s13277-015-3349-7. Epub 2015 Mar 28.

PMID:
25820700
17.

Limb-Bud and Heart Attenuates Growth and Invasion of Human Lung Adenocarcinoma Cells and Predicts Survival Outcome.

Deng M, Yu R, Wang S, Zhang Y, Li Z, Song H, Liu B, Xu L, Wang X, Zhang Z, Lv Q, Wang X, Che X, Qu X, Liu Y, Hu X.

Cell Physiol Biochem. 2018;47(1):223-234. doi: 10.1159/000489801. Epub 2018 May 18.

18.

CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis.

Truesdell P, Ahn J, Chander H, Meens J, Watt K, Yang X, Craig AW.

Oncogene. 2015 Jul;34(27):3527-35. doi: 10.1038/onc.2014.280. Epub 2014 Sep 1.

19.

Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.

Xu P, Zhao M, Liu Z, Liu Y, Chen Y, Luo R, Fang W.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):15887-94. eCollection 2015.

20.

Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.

Cho HJ, Lee S, Ji YG, Lee DH.

PLoS One. 2018 Nov 12;13(11):e0207204. doi: 10.1371/journal.pone.0207204. eCollection 2018.

Supplemental Content

Support Center